Related Experiment Video
Updated: May 30, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Transverse myelitis in systemic lupus erythematosus]
María Luisa Velloso Feijoo1, Francisco García Hernández, Celia Ocaña Medina
1Unidad de Colagenosis. Servicio de Medicina Interna. Hospital Universitario Virgen del Rocío. Sevilla. España.
Reumatologia Clinica
|July 29, 2011
Summary
Transverse myelitis (TM) affects 0.92% of systemic lupus erythematosus (SLE) patients. Antiphospholipid antibodies are common, and anticoagulation or antiplatelet therapy improves outcomes in these TM patients.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...